Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-12-16

FDA Approved: MORPHINE SULFATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Morphine Sulfate by Hospira, Inc., resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)